PET is able to recognize when a bone injury is severe enough that resting is indicated to prevent breakdown, but PET also ...

DUBLIN--(BUSINESS WIRE)--The "Positron Emission Tomography (PET) Scanners - A Global Market Overview" report has been added to ResearchAndMarkets.com's offering. The global market for Positron ...

A multicenter study led by London Health Sciences Centre Research Institute (LHSCRI), Lawson Research Institute of St. Joseph ...

Positron Emission Tomography–Computed Tomography (PET-CT) Versus No PET-CT in the Management of Potentially Resectable Colorectal Cancer Liver Metastases: Cost Implications of a Randomized Controlled ...

SAN DIEGO, September 18, 2025--(BUSINESS WIRE)--Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a clinical-stage biopharmaceutical company pioneering differentiated therapies ...

Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a clinical-stage biopharmaceutical company pioneering differentiated therapies for the treatment of neuroscience, inflammation ...

Niagara Falls, NY, Aug. 26, 2024 (GLOBE NEWSWIRE) -- Positron Corporation (POSC), a leading molecular imaging medical device company offering PET and PET-CT (Positron Emission Tomography/Computed ...

A brain exercise a day might keep you current—it might even revive your brain chemistry. In a landmark clinical trial led by ...

Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian healthcare company announces that it has completed its previously announced name ...